KEGG: xla:380544
UniGene: Xl.29371
ABHD6-B in Xenopus laevis functions primarily as a lipase that hydrolyzes monoacylglycerols (MAGs), particularly 2-arachidonoylglycerol (2-AG), an important endocannabinoid. ABHD6 is part of the α/β hydrolase domain-containing family and plays key roles in lipid metabolism. In Xenopus, ABHD6 serves multiple functions:
Degradation of bis(monoacylglycero)phosphate (BMP), which is enriched in late endosomes/lysosomes
Regulation of endocannabinoid signaling through 2-AG hydrolysis
Participation in late endosomal/lysosomal lipid-sorting machinery
Unlike mammals which express a single ABHD6 gene, Xenopus laevis expresses two homeologs (abhd6-a and abhd6-b) due to its pseudotetraploid genome resulting from genome duplication approximately 30 million years ago .
Xenopus laevis ABHD6-B shares significant structural homology with mammalian ABHD6, though with some key differences:
Both contain a characteristic α/β hydrolase fold with a catalytic triad (Ser, Asp, His) in the active site
The protein contains eight central β-sheets that form a partial β-barrel surrounded by eight α-helices
A lid-domain composed of residues 151-225 fashioned by helices α4-α6 covers the β-sheets and active site
The Xenopus enzyme maintains the conserved transmembrane domain that anchors the protein to membranes
Sequence analysis shows preservation of key functional domains while maintaining species-specific variations
Structural conservation between Xenopus and mammalian ABHD6 suggests evolutionary importance of this enzyme, similar to how other proteins like the LDL receptor maintained structural conservation between species .
Several expression systems have proven effective for producing recombinant Xenopus proteins including ABHD6-B:
E. coli-based expression:
Prokaryotic expression using pET or pGEX vectors with BL21(DE3) cells
Often requires optimization of codons for bacterial expression
Typically produces inclusion bodies requiring refolding protocols
Better suited for partial protein domains than full-length ABHD6-B
Xenopus oocyte/embryo expression:
Direct mRNA injection into Xenopus oocytes or early embryos
Allows post-translational modifications similar to native protein
Embryos show high protein production capacity with low background
Can be used with genetic code expansion technologies for specialized studies
Mammalian cell expression:
HEK293T or COS-7 cells using pcDNA3.1 or similar vectors
Provides proper folding and post-translational modifications
Allows study of membrane integration and trafficking
Recommended for full-length ABHD6-B with transmembrane domains
Each system offers distinct advantages depending on downstream applications and desired protein characteristics.
Understanding the membrane association and subcellular localization of Xenopus ABHD6-B requires multiple complementary techniques:
Subcellular fractionation:
Differential centrifugation of Xenopus tissue homogenates or cells expressing recombinant ABHD6-B
Sucrose density-gradient centrifugation to separate organelles
Western blot analysis of fractions using anti-ABHD6 antibodies and organelle markers
Confocal microscopy and live cell imaging:
Fluorescent protein fusions (GFP-ABHD6-B) for live cell tracking
Immunofluorescence with anti-ABHD6 antibodies in fixed cells/tissues
Co-localization studies with markers for late endosomes/lysosomes
Membrane integration analysis:
Alkaline carbonate extraction to distinguish peripheral vs. integral membrane proteins
Protease protection assays to determine topology
Hydrogen exchange mass spectrometry (HX-MS) using nanodisc technology to identify membrane-interacting domains
ABHD6 co-localizes with late endosomes/lysosomes in mammalian cells and exhibits activity at cytosolic pH rather than acidic lysosomal pH, suggesting it degrades BMP exported from acidic organelles or de novo-formed BMP . Similar approaches would be valuable for characterizing Xenopus ABHD6-B localization.